Unified Patent Court (UPC) analytics are now available. Check here

TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Organic Medicines, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Organic Medicines technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Organic Medicines

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Organic Medicines industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Organic Medicines industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Organic Medicines industry

EP4037666Improvements To Devices And Methods For Delivery Of Substances To AnimalsRUMINANT BIOTECHJan 31, 2025WRAYS SOLUTIONS
EP3494961Compositions And Methods For Treating Chronic Inflammation And Inflammatory DiseasesINFIRST HEALTHCAREJan 10, 2025HAMM&WITTKOPP PATENTANWALTE PARTMBB
EP3402812Modulators Of Zinc Activated Cation ChannelDIGNITY HEALTHDec 13, 2024BLUM
EP3934624Topical Composition And Methods Of Measuring The Cooling Abaility Of A Topical CompositionFUTURA MEDICAL DEVELOPMENTSDec 9, 2024AERA
EP3973987Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSOct 10, 2024HAMPTON KNOWLES
EP3973987Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYOct 9, 2024SECERNA
EP3973987Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSOct 1, 2024DR H ULRICH DORRIES
EP4084778Amorphous Kinase Inhibitor Formulations And Methods Of Use ThereofDECIPHERA PHARMACEUTICALSAug 1, 2024ALFRED E TIEFENBACHER
EP4114465Anti-Ifnar1 Dosing Regime For Subcutaneous InjectionASTRAZENECAMay 29, 2024MAIWALD
EP3682870Method For The Preparation Of Easily Consumable Tablets Containing Ginkgo Biloba Leaf ExtractDR WILLMAR SCHWABEMay 17, 2024KORTH

To stay ahead in the competitive Organic Medicines industry, companies are constantly innovating. Here are the top patents facing oppositions in the Organic Medicines industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP3395339Dec 11, 2019Rapid Dissolution Formulation Of A Cinacalcet HclAMGEN11
EP3395338May 1, 2019Rapid Dissolution Formulation Of Cinacalcet HclAMGEN7
EP3973987Jan 10, 2024Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS6
EP3230316Jan 5, 2022Treatment Of Age Related Macular Degeneration With A Small Active Choroidal Neovascularization LesionBAYER HEALTHCARE6
EP2397142Jul 27, 2022Use Of Dpp Iv InhibitorsBOEHRINGER INGELHEIM5
EP2322153Oct 8, 2014Use Of Hif Alpha Stabilizers For Enhancing ErythropoiesisFIBROGEN4
EP3335708Dec 11, 2019Administration Of Gamma Hydroxybutyrate With Monocarboxylate TransportersJAZZ PHARMACEUTICALS IRELAND4
EP2395983Apr 8, 2020Pharmaceutical Composition Comprising A Sglt2 Inhibitor, A Dpp-Iv Inhibitor And Optionally A Further Antidiabetic Agent And Uses ThereofBOEHRINGER INGELHEIM3
EP3107575Sep 1, 2021Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGY3
EP3135275May 13, 2020Pharmaceutical Composition Capable Of The Incorporation Of Lenalidomide In Various Crystalline ModificationsGRINDEKS3